Pharmaceutical Executive, Mar 1, 2009 - Pharmaceutical Executive

ADVERTISEMENT

Pharmaceutical Executive, Mar 1, 2009
Features
The New Sales Force
By Brittany Agro
The arms race is over, and it's time to reinvent pharma sales. Here's what forward-looking companies are experimenting with—and how it's working
Ad Stars 2009
By Brittany Agro
The faces (and talent!) behind the year's best ads
Fifth Annual Press Audit: Safety in the Spotlight
By Stephen J. Porth , George P. Sillup
Reporters pass on the typical litany of lightning-rod issues and instead devote more than three-quarters of all coverage in 2008 to drug safety—and the regulators who enforce it.
Attack of the Monster Merger
By Walter Armstrong
Just when you thought it was safe to go back into M&A, the mega merger returns. What's right about Pfizer-Wyeth, and what's scary.
Columns
Activate Your Audience
Marketers need to reach beyond disease awareness to spark "movement" communications campaigns
The End of Quid Pro Quo
Exhibitor alert: Tchotchke entitlement is out, information immersion is in
Leadership
Learning From Fast-Action Obama
By Sander Flaum
Our new president came in with a 100-day plan. His execution may be less than perfect, but his make-change approach inspires confidence
From the Editor
Against Gravity
By Patrick Clinton
The worst thing about working for most corporations is the inevitable downward pull they exert even on the best of us. That's why it's always sad to lose a company that learned to fight back.
Washington Report
Through the Looking Glass
By Jill Wechsler
The latest buzzword in pharma is "transparency"

ADVERTISEMENT

Click here